|
|
|||
|
||||
OverviewThis book provides an update for any gastroenterologist, medical or surgical, with an interest in inflammatory bowel disease. Clinically important aspects of diagnosis and treatment are covered and underpinned by scientific mechanisms. It is an exciting book which looks into the future as well as informing current practice. It includes up-to-date research findings at the highest scientific level. Full Product DetailsAuthor: D.P. Jewell , J.F. Colombel , A.S. Pena , A. TrommPublisher: Springer-Verlag New York Inc. Imprint: Springer-Verlag New York Inc. Edition: 2006 ed. Volume: 147 Weight: 0.602kg ISBN: 9781402043154ISBN 10: 1402043155 Pages: 265 Publication Date: 24 February 2006 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Out of Stock Indefinitely Availability: Out of stock Table of ContentsList of principal contributors. List of chairpersons. Preface.- SECTION I: DIAGNOSIS. 1 Role of capsule encoscopy in Crohn's disease. 2 Endoscopy in Crohn's disease. 3 Colitis diagnosis and therapeutic strategies - how, what and when to biopsy.- SECTION II: MICROSCOPIC COLITIS. 4 Epidemiology of microscopic colitis. 5 Microscopic colitis: histological classification. 6 Mechanisms of pathogenesis in microscopic colitis. 7 Microscopic colitis: treatment.- SECTION III: PREDICTING OUTCOMES. 8 Predicting the natural history of inflammatory bowel disease. 9 Who gets extra-intestinal manifestations? 10 Colitis: predicting outcomes -- who gets cancer?.- SECTION IV: CORTICOSTEROID THERAPY. 11 Mechanisms of steroid action and resistance in inflammatory bowel disease. 12 Budesonide for ulcerative colitis. 13 How do I use steroids in Crohn's disease? 14 Why corticosteroids should not be used as first-line therapy for Crohn's disease.- SECTION V: AZATHIOPRINE. 15 Azathioprine: molecular mechanism of action. 16 Pharmacogenetics of azathioprine - useful in clinical practice? 17 Azathioprine: long-term side-effects. 18 State-of-the-Art Lecture: Trials and complications of ileal pouch surgery.- SECTION VI: IMMUNOMODULATORY THERAPY. 19 Biologics in ulcerative colitis.- SECTION VII: CANCER AND IBD. 20 Diagnosis of colitis associated dysplasia: new colonoscopic techniques. 21 Can we prevent cancer using current drugs? 22 Management of low-grade dysplasia in inflammatory bowel disease. 23 Low-grade dysplasia in flat mucosa: is it relevant?.- SECTION VIII: NEW THERAPEUTIC APPROACHES. 24 Leucocytapheresis. 25 Helminths and immune.- modulation of inflammatory bowel disease. 26 Probiotics for inflammatory bowel disease.- IndexReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||